| Bacillus cereus and related species FA Drobniewski Clinical microbiology reviews 6 (4), 324-338, 1993 | 1121 | 1993 |
| Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004 A Wright, G Bai, L Barrera, F Boulahbal, N Martin-Casabona, C Gilpin, ... Morbidity and Mortality Weekly Report 55 (11), 301-306, 2006 | 962 | 2006 |
| The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study W Hoefsloot, J Van Ingen, C Andrejak, K Ängeby, R Bauriaud, P Bemer, ... European Respiratory Journal 42 (6), 1604-1613, 2013 | 858 | 2013 |
| Worldwide emergence of extensively drug-resistant tuberculosis NS Shah, A Wright, GH Bai, L Barrera, F Boulahbal, N Martín-Casabona, ... Emerging infectious diseases 13 (3), 380, 2007 | 777 | 2007 |
| High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial AR Martineau, PM Timms, GH Bothamley, Y Hanifa, K Islam, AP Claxton, ... The Lancet 377 (9761), 242-250, 2011 | 769 | 2011 |
| A systematic review of rapid diagnostic tests for the detection of tuberculosis infection J Dinnes, J Deeks, H Kunst, A Gibson, E Cummins, N Waugh, ... Health technology assessment 11 (3), 2007 | 766 | 2007 |
| Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study TM Walker, TA Kohl, SV Omar, J Hedge, CDO Elias, P Bradley, Z Iqbal, ... The Lancet infectious diseases 15 (10), 1193-1202, 2015 | 616 | 2015 |
| Evolution and transmission of drug-resistant tuberculosis in a Russian population N Casali, V Nikolayevskyy, Y Balabanova, SR Harris, O Ignatyeva, ... Nature genetics 46 (3), 279-286, 2014 | 587 | 2014 |
| Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage M Merker, C Blin, S Mona, N Duforet-Frebourg, S Lecher, E Willery, ... Nature genetics 47 (3), 242-249, 2015 | 576 | 2015 |
| Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance A Wright, M Zignol, A Van Deun, D Falzon, SR Gerdes, K Feldman, ... The Lancet 373 (9678), 1861-1873, 2009 | 549 | 2009 |
| Tuberculous meningitis G Thwaites, TTH Chau, NTH Mai, F Drobniewski, K McAdam, J Farrar Journal of Neurology, Neurosurgery & Psychiatry 68 (3), 289-299, 2000 | 475 | 2000 |
| Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays TR Gingeras, G Ghandour, E Wang, A Berno, PM Small, F Drobniewski, ... Genome research 8 (5), 435-448, 1998 | 428 | 1998 |
| Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement C Lange, I Abubakar, JWC Alffenaar, G Bothamley, JA Caminero, ... European Respiratory Journal 44 (1), 23-63, 2014 | 424 | 2014 |
| Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment AK Coussens, RJ Wilkinson, Y Hanifa, V Nikolayevskyy, PT Elkington, ... Proceedings of the National Academy of Sciences 109 (38), 15449-15454, 2012 | 404 | 2012 |
| False-positive COVID-19 results: hidden problems and costs E Surkova, V Nikolayevskyy, F Drobniewski The lancet respiratory medicine 8 (12), 1167-1168, 2020 | 386 | 2020 |
| Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia F Drobniewski, Y Balabanova, V Nikolayevsky, M Ruddy, S Kuznetzov, ... Jama 293 (22), 2726-2731, 2005 | 369 | 2005 |
| Snapshot of Moving and Expanding Clones of Mycobacterium tuberculosis and Their Global Distribution Assessed by Spoligotyping in an International Study I Filliol, JR Driscoll, D Van Soolingen, BN Kreiswirth, K Kremer, ... Journal of Clinical Microbiology 41 (5), 1963-1970, 2003 | 343 | 2003 |
| Genetic Association and Expression Studies Indicate a Role of Toll-Like Receptor 8 in Pulmonary Tuberculosis S Davila, ML Hibberd, R Hari Dass, HEE Wong, E Sahiratmadja, ... PLoS genetics 4 (10), e1000218, 2008 | 331 | 2008 |
| Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs World Health Organization World Health Organization, 2008 | 328 | 2008 |
| Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing CRyPTIC Consortium and the 100,000 Genomes Project New England Journal of Medicine 379 (15), 1403-1415, 2018 | 321 | 2018 |
